glp-1/glucagon dual receptor agonist Efficacy of glucagon-like peptide-1 and estrogen in pancreatic islets protection and pre-clinical models of insulin-deficient diabetes Oral GLP-1-Based Therapeutics in the

use in separate formulations) Sodium Bicarbonate Iron or copper ions (destabilizing)

Overexpression of GSTP1 in MCF-7 cells by using the DNA transfection vector enhanced autophagy and down-regulation of GSTP1 through RNA interference in MCF-7/ADR cells decreased autophagy

Oral sup-plementation with OEA has been shown to influence the levels of Anti-Mllerian Hormone (AMH), fasting blood sugar (FBS), the Homeostasis Model Assessment for Insulin Resistance (HOMA IR), tumor necrosis factor-alpha (TNF-), and C-reactive protein (CRP), significantly decreasing their serum concentration starting from a dose of 125 mg/day, over eight weeks 5

[PubMed: 40204768] [Free PMC Article] Carvas AO, Leuthardt A, Kulka P, et al